Partial Response to Proton Pump Inhibitors (PPI) Treatment: The Cost to Society and the Burden to the Patient - a Study in the US

Completed

Conditions studied: Gastroesophageal Reflux Disease (GERD)

In brief

The purpose of this study is to describe common treatment pathways, to collect health care utilization data and to assess symptom load as well as impact of symptoms on daily life in GERD patients who are partial-responders to PPI treatment.

Key facts

Study ID

NCT00795093

Run by

AstraZeneca

People needed

552

Starts

2008-11-01

Expected to finish

2010-01-01

Last updated by the study team

2010-05-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• At least 6 month history of GERD symptoms
• Treated with unchanged optimized PPI treatment for any GERD indication during a consecutive 4 week period
• Remaining GERD symptoms despite optimized PPI treatment
• Able to read and write in US English, and able to comply with study requirements

You may not qualify if…

• Patients that have not experienced any GERD symptom improvement at all during PPI treatment
• Involvement in the planning or conduct of the study
• Involvement in any other observational study or in any clinical study at the time of this study or during the last 6 months

Where it is running

• Research Site — Pheonix, Arizona, United States
• Research Site — Tucson, Arizona, United States
• Research Site — Concord, California, United States
• Research Site — Lancaster, California, United States
• Research Site — Los Banos, California, United States
• Research Site — Solana Beach, California, United States
• Research Site — Newark, Delaware, United States
• Research Site — Altamonte Springs, Florida, United States
• Research Site — Cocoa, Florida, United States
• Research Site — DeFuniak Springs, Florida, United States
• Research Site — Largo, Florida, United States
• Research Site — Maitland, Florida, United States
• Research Site — Miami, Florida, United States
• Research Site — Naples, Florida, United States
• Research Site — Ocala, Florida, United States
• Research Site — Orlando, Florida, United States
• Research Site — Palm Harbor, Florida, United States
• Research Site — Peonia, Florida, United States
• Research Site — Tampa, Florida, United States
• Research Site — Columbus, Georgia, United States
• Research Site — Roswell, Georgia, United States
• Research Site — Royston, Georgia, United States
• Research Site — Snellville, Georgia, United States
• Research Site — Belleville, Illinois, United States
• Research Site — Leeds, Alabama, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.